海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Cetuximab and Best Supportive Care Compared with Best Supportive Care Alone in Treating Patients with Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer.
- Colorectal Cancer - stage IV colon cancer - recurrent colon cancer - recurrent rectal cancer - stage IV rectal cancer
- Australia
- 2004-07-28
Not recruiting
- Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
- Colorectal Cancer;Quality of Life
- Australia, Canada
- 2004-03-08
Not recruiting
- Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
- HIV-1 Infections;HIV Infections;HIV-1 Infections;HIV Infections;HIV-1 Infections;HIV Infections;HIV-1 Infections;HIV Infections
- Kenya, Uganda
- 2007-11-08
Not recruiting
- A pilot study on the cutaneous toxicities in oncology patients on Epidermal Growth Factor Receptor inhibitors: skin physiology, clincial manifestations and quality of life.
- Cutaneous side effects on oncology patients on EGFRIs
- Australia
- 2008-05-26
- A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
- HIV-1
- Brazil, Germany, Italy, Malaysia, Other, Poland, Portugal, South Africa, Spain, Taiwan, Ukraine, United Kingdom, United States of America
- 2010-06-28
Not Recruiting
- A Phase 2, Randomized, Double-Blind Study of Ipilimumab Administered at 3 mg/kg vs 10 mg/kg in Adult Subjects With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer Who Are Asymptomatic or Minimally Symptomatic
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Chile, France, Germany, Italy, Mexico, Netherlands, Spain, United Kingdom, United States
- 2015-10-23
Authorised
- To determine the efficacy, safety and tolerability of two approved medicines, dolutegravir (DTG) plus lamivudine (3TC) taken together as a single tablet, compared with subjects taking their current tenofovir alafenamide (TAF)-based regimen (TBR) for the treatment of HIV-1 infected adults in whom the HIV-1 virus is currently suppressed.
- Human Immunodeficiency Virus-1 infection MedDRA version: 20.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom, United States
- 2018-01-17
Authorised
- To determine the efficacy, safety and tolerability of two approved medicines, dolutegravir (DTG) plus lamivudine (3TC) taken together as a single tablet, compared with subjects taking their current tenofovir alafenamide (TAF)-based regimen (TBR) for the treatment of HIV-1 infected adults in whom the HIV-1 virus is currently suppressed.
- Human Immunodeficiency Virus-1 infection MedDRA version: 20.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Belgium, Canada, France, Germany, Japan, Netherlands, Spain, United Kingdom, United States
- 2018-01-11
Not recruiting
- Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)
- Heterozygous Familial Hypercholesterolemia;Elevated Cholesterol;Heterozygous Familial Hypercholesterolemia;Elevated Cholesterol;Heterozygous Familial Hypercholesterolemia;Elevated Cholesterol
- Canada, Czechia, Denmark, Israel, Netherlands, South Africa, Spain, Sweden, United Kingdom, United States
- 2018-01-02
Recruiting
- A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN
- C3 Glomerulonephritis;Dense Deposit Disease;Membranoproliferative Glomerulonephritis, Type II;C3 Glomerulopathy;Immune Complex Mediated Membranoproliferative Glomerulonephritis
- Australia, Belgium, Netherlands
- 2017-04-12
Authorised
- A study in people with type 1 diabetes to determine how well a meal-time insulin, LY900014, controls diabetes compared to Humalog (insulin lispro) when both are used along with a long-acting insulin.
- Type 1 Diabetes MedDRA version: 20.0 Level: LLT Classification code 10020639 Term: Hyperglycemia System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Argentina, Australia, Austria, Brazil, Germany, Greece, India, Italy, Japan, Mexico, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United States
- 2017-04-03
Recruiting
- Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men
- Obesity;Dyslipidemias
- Egypt
- 2018-10-29
Not Recruiting
- Non small cell lung cancer trial of durvalumab and tremelimumab in advanced epidermal growth factor receptor (EGFR) mutant disease.
- EGFR mutant advanced non small cell lung cancer.; EGFR mutant advanced non small cell lung cancer.;Cancer - Lung - Non small cell
- Australia, Taiwan, Province Of China
- 2018-10-23
Not Recruiting
- To study the effect of a novel drug (Semaglutide) which has half-life of around 1 week, suitable for once-weekly injection compared with bolus pre-meal insulin 3 times daily, both added to metformin (oral anti-diabetic drug) & insulin glargine (long acting insulin) in patients with type 2 diabetes
- Type 2 diabetes mellitus
- Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Germany, Greece, Hungary, India, Latvia, Lithuania, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, South Africa, Spain, The former Yugoslav Republic of Macedonia, Turkey
- 2018-10-05
Not Recruiting
- Vitamin B1 (thiamine) administration in enterally-fed critically ill patients with hypophosphatemia: A prospective, randomised clinical trial
- Critical illness;Hypophosphatemia;Thiamine deficiency;enteral nutrition; Critical illness Hypophosphatemia Thiamine deficiency enteral nutrition;Metabolic and Endocrine - Other metabolic disorders;Diet and Nutrition - Other diet and nutrition disorders
- Australia, New Zealand
- 2019-01-25
Recruiting
- International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
- ;C91 - Lymphoid leukaemia
- Australia, Austria, Chile, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Israel, Italy, Lithuania, Netherlands, Norway, Poland, Slovakia, Sweden, United Kingdom, United States
- 2019-05-14
Recruiting
- Effect of Omega 3 Fatty Acids on the Vascular Calcification Biomarkers Fetuin A and Osteoprotegerin in Patients With CRF
- Chronic Renal Failure
- Egypt
- 2019-06-09
Not recruiting
- A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
- Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3;Squamous Lung Cancer With FGFR1 Amplification;Bladder Cancer With FGFR3 Mutation or Fusion;Advanced Solid Tumors With FGFR1 Amplication;Advanced Solid Tumors With FGFR2 Amplication;Advanced Solid Tumors With FGFR3 Mutation
- Australia, Austria, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Netherlands, Singapore, Spain, Taiwan, Thailand, Turkey, United States
- 2009-10-27
Recruiting
- Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
- Diabetic Polyneuropathy;Diabetes Mellitus;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Diabetes Complications;Diabetic Polyneuropathy;Diabetes Mellitus;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Diabetes Complications;Diabetic Polyneuropathy;Diabetes Mellitus;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Diabetes Complications;Diabetic Polyneuropathy;Diabetes Mellitus;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Diabetes Complications
- Australia, Canada, United Kingdom, United States
- 2015-04-17
Not recruiting
- Diabetes Attitudes Wishes and Needs
- Diabetes;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Relatives to/Carers of Patients;Healthcare Professionals;Diabetes;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Relatives to/Carers of Patients;Healthcare Professionals;Diabetes;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Relatives to/Carers of Patients;Healthcare Professionals;Diabetes;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 2;Relatives to/Carers of Patients;Healthcare Professionals
- Algeria, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom, United States
- 2012-01-04
